🔬 MBNL1 Identified as a Potential Cancer Drug Target
Published by OOPSONLINE.IN · Source: Medical Xpress · 1 min read · · Updated
What actually happened
Scientists from St. Jude Children's Research Hospital and collaborators have discovered that the RNA-binding protein MBNL1 promotes the growth of a form of childhood leukemia characterized by KMT2A gene rearrangements. The finding identifies MBNL1 as a promising therapeutic target for future drug development. The results were published August 7 in Science Advances.
Key points
- Jude Children's Research Hospital and collaborators have discovered that the RNA-binding protein MBNL1 promotes the growth of a form of childhood leukemia characterized by KMT2A gene rearrangements.
- The finding identifies MBNL1 as a promising therapeutic target for future drug development.
- The results were published August 7 in Science Advances.
Summary based on data provided by Medical Xpress. Full article available at the original publisher.
- #science
- #mbnl1
- #identified